Acyclovir for herpetic gingivostomatitis in children.

Area of Science:

• Pediatric infectious diseases
• Oral medicine
• Virology

Background:

• Gingivostomatitis, a common preschool illness caused by herpes simplex virus type 1 (HSV-1), presents a significant health burden.
• Clinical observation suggests a substantial number of preschool children are affected annually.

Purpose of the Study:

• To evaluate the efficacy of oral acyclovir for treating primary herpetic gingivostomatitis in preschool children.
• To determine optimal timing and indications for antiherpetic therapy in this pediatric population.

Main Methods:

• A review of existing literature, including a single randomized controlled trial, was conducted.
• The study focused on identifying criteria for initiating antiviral treatment.

Main Results:

• Most children with primary gingivostomatitis remain asymptomatic.
• A subset of children experience severe pain, discomfort, and dehydration, necessitating intervention.
• Evidence suggests treatment initiation within 72 hours of symptom onset may be beneficial for symptomatic cases.

Conclusions:

• While not all children require treatment, severe symptoms like pain and dehydration warrant consideration of oral acyclovir.
• Current evidence is limited, emphasizing the need for careful patient selection and timely intervention within the first 72 hours of symptom onset.
• Further large-scale, well-designed studies are needed to establish definitive treatment guidelines for pediatric gingivostomatitis.